| Current Price | $16.52 | Mkt Cap | $5.0B |
|---|---|---|---|
| Open | $16.48 | P/E Ratio | 15.57 |
| Prev. Close | $16.52 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $16.30 - $16.95 | Volume | 7,012,490 |
| 52-Wk Range | $13.67 - $22.06 | Avg. Daily Vol. | 3,884,698 |
A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.
| Current Price | $16.52 | Mkt Cap | $5.0B |
|---|---|---|---|
| Open | $16.48 | P/E Ratio | 15.57 |
| Prev. Close | $16.52 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $16.30 - $16.95 | Volume | 7,012,490 |
| 52-Wk Range | $13.67 - $22.06 | Avg. Daily Vol. | 3,884,698 |
The best Bull and Bear pitches based on recency and number of recommendations.
I often eschew Biotech at this point in history because the investments hinge on single do or die events like FDA approval. It reminds me of a Red OR Black bet on a craps table. That being said Exelixis caught my attention due to its partnerships… More
This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.
Read the most recent pitches from players about EXEL.
Recs
poluh2k
(43.85)
Submitted: 11/8/2019 4:56:06 AM :
Start Price:
$15.28
NASDAQ:EXEL Score:
+27.49
Very good data
Recs
genedom
(93.38)
Submitted: 4/24/2019 2:58:54 PM :
Start Price:
$20.73
NASDAQ:EXEL Score:
-5.06
potential buyout target. If that happens, the target price could be 30-33. Without buyout, there might be a pushup around June for the ASCO meeting.
Recs
SpartanMAC
(< 20)
Submitted: 11/12/2018 7:28:55 AM :
Start Price:
$16.57
NASDAQ:EXEL Score:
+10.17
EBITD/EV is calculated at 8%. Matched on HMG screen. Estimated future value calculated at 233 (future growth rate estimate of 46% :0).
Find the members with the highest scoring picks in EXEL.
beave35 (88.63) Score: +1,151.36
The Score Leader is the player with the highest score across all their picks in EXEL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Playa14 | < 20 |
|
|
5Y | $1.27 | +1,200.79% | +19.13% | +1,181.66 | 0 Comment | |
| beave35 | 88.63 | 12/23/2014 |
|
5Y | $1.30 | +1,170.67% | +19.31% | +1,151.36 | 0 Comment | |
| tomkao | < 20 | 12/15/2014 |
|
5Y | $1.40 | +1,080.00% | +23.10% | +1,056.90 | 0 Comment | |
| jack0071 | 70.98 | 12/3/2014 |
|
5Y | $1.43 | +1,055.24% | +19.71% | +1,035.54 | 0 Comment | |
| portefeuille | 98.36 | 12/15/2014 |
|
5Y | $1.44 | +1,047.22% | +22.86% | +1,024.36 | 0 Comment | |
| akoniec | 33.97 | 10/9/2014 |
|
3Y | $1.55 | +965.81% | +26.39% | +939.41 | 0 Comment | |
| dcoyne13 | 40.28 | 9/16/2014 |
|
5Y | $1.62 | +919.69% | +24.14% | +895.55 | 0 Comment | |
| foolerhoff | 86.45 | 1/6/2015 |
|
5Y | $1.64 | +907.32% | +22.79% | +884.53 | 0 Comment | |
| new2fool23 | 30.95 | 1/5/2015 |
|
1Y | $1.67 | +889.22% | +21.54% | +867.68 | 0 Comment | |
| garisonmp3z | < 20 | 1/5/2015 |
|
5Y | $1.67 | +889.22% | +21.54% | +867.68 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
